Skip to main content
Log in

Typ-2-Diabetes und Ernährung

Fettleber: Wirkt Kaffee tatsächlich protektiv?

  • Journal club
  • Published:
Info Diabetologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur:

  1. Marventano S, Salomone F, Godos J et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin Nutr. 2016;35:1269-81

  2. Powell EE, Wong V, Rinella M et al. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212-24

  3. Wang H, Guan W, Yang W et al. Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway. PLoS One. 2014;9:e92482

  4. Hsu SJ, Lee FY, Wang SS et al. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology. 2015;61:1672-84

  5. Brandt A, Nier A, Jin CJ et al. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. Redox Biol. 2019;21:101092

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karsten Müssig.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müssig, K. Fettleber: Wirkt Kaffee tatsächlich protektiv?. Info Diabetol 17, 30–31 (2023). https://doi.org/10.1007/s15034-023-4507-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15034-023-4507-4

Navigation